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12 Abstract
13 Purpose To determine the repeatability of mesopic high-
14 contrast (HC) and low-contrast (LC) visual acuity (VA) mea-
15 surements made at distance and near in healthy young indi-
16 viduals. While the repeatability of photopic VA is well-
17 known, there is a lack of information with regard to the
18 repeatability of VA measured under low luminance
19 conditions.
20 Methods In two different sessions 1 week apart, best-
21 corrected monocular VA was determined using HC (96 %)
22 and LC (10 %) ETDRS charts under mesopic luminance
23 conditions (0.75 cd/m2) at distance (HCD, LCD) and near
24 (HCN, LCN) in 47 healthy subjects aged 22.9±6.8 years.
25 Repeatability was estimated by the Bland and Altmanmethod,
26 whereby the mean difference (MD) and the 95 % limits of
27 agreement were determined as the coefficient of repeatability
28 (COR).
29 Results Mean logMARVA values were HCD = 0.09, LCD =
30 0.44, HCN = 0.21, and LCN = 0.57. Mean differences in
31 measurements between sessions 1 and 2 were not significant,
32 and low in clinical terms (≤1 letter). Repeatability was better
33 for the distance measurements at both high and lowcontrast
34 (COR HCD ±0.11 and COR LCD ±0.11 logMAR vs COR HCN
35 ±0.15 and COR LCN ±0.16 logMAR), and MDs were also
36 slightly closer to zero for the distance measurements. Similar
37 repeatability was observed between HC and LC VA, both at
38 distance and near.
39 Conclusions In mesopic conditions, ETDRS charts offer re-
40 peatable best-corrected monocular VA measurements. The
41 criterion for a significant change in logMAR VA was 1 line
42 at distance and 1.5 lines at near.
43Keywords ETDRS .Repeatability .Visual acuity .Mesopic .
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45Introduction
46Visual acuity (VA) is probably the most widely used vision
47test. Besides reflecting the integrity of the central visual path-
48way, the VA test is used for screening, refractive error deter-
49mination and monitoring treatment or disease progression.
50Although photopic high-contrast VA is often considered to
51be the single most important indicator of the quality of vision
52[1], recent evidence suggests that mesopic VA may be an
53earlier indicator of vision change in ocular diseases. Several
54inherited and acquired disorders involving both rods and
55cones can affect mesopic vision [2]. Accordingly, impaired
56night-time vision is among the earliest signs of a range of
57retinal diseases including diabetic retinopathy [3], retinosis
58pigmentosa [4], retinitis punctata albescens [5, 6], central
59serous chorioretinopathy [7], and melanoma-associated reti-
60nopathy [8]. Mesopic VA is also a sensitive indicator of
61impaired macular function in eyes with early age-related
62macular degeneration (AMD), which may be modified before
63any photopic HCVA alterations occur [9]. Moreover, mesopic
64VA is able to predict the risk of future VA loss in subjects with
65geographic atrophy resulting from AMD [10].
66High-contrast VA measurements are not necessarily sensi-
67tive to vision loss related to light scatter (e.g., cataract) [11],
68wavefront aberrations (e.g., keratoconus) [12], or refractive
69surgery [13]. Vision tests using reduced contrast targets or
70conducted at mesopic light levels may be more sensitive [14,
7115] to vision loss, given that the impact of a small change in
72retinal image quality in healthy eyes is best reflected by a
73corresponding change in low-contrast (LC) mesopic VA rather
74than a change in high-contrast (HC) photopic VA [16]. The
75exclusive use of HC VA in clinical settings may cause
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76 discrepancy between a clinician’s findings and patients’ self-
77 reported visual function. Most daily tasks involve visual con-
78 ditions far from those of the well-illuminated white test chart
79 with black letters [17], and mesopic vision is important, par-
80 ticularly when driving at night [18].
81 To correctly interpret changes in VAmeasures, the clinician
82 needs to know the repeatability of a given VA test. This
83 repeatability can be improved through the use of charts based
84 on the logMAR design [19, 20] such as the Bailey–Lovie and
85 the Early Treatment Diabetic Retinopathy Study (ETDRS)
86 test, by incorporating standard measurement procedures [21,
87 22], and by letter-by-letter scoring. In prior work [23, 24, 20,
88 25, 26], good test–retest reliability was observed of photopic
89 VA measurements made both at high and low contrast using
90 the ETDRS and Bailey–Lovie tests. However, as far as we
91 know, no study has addressed the repeatability of mesopic
92 distance and near VA measurements made using high- and
93 low-contrast ETDRS charts in healthy subjects. This was the
94 objective of the present study.
95 Materials and methods
96 Subjects
97 The study was conducted at the Faculty of Optics and Op-
98 tometry, Universidad Complutense deMadrid, Madrid, Spain.
99 Measurements were obtained in 47 healthy subjects, 15 men
100 and 32 women, of mean age 22.9±6.8 years (18–43 years).
101 Inclusion criteria were a best-corrected distance visual
102 acuity (CDVA) of at least 0.1 logMAR (20/25) and no ocular
103 abnormality, including media opacity. Subjects were excluded
104 if they had any systemic disease or eye disease, or had under-
105 gone refractive surgery.
106 The guidelines of the Declaration of Helsinki were adhered
107 to, and full approval for the study was obtained from our
108 institution’s review board. Each subject gave their informed
109 consent to participate.
110 Visual acuity
111 Best-corrected visual acuity was measured monocularly in
112 two separate sessions 1 week apart. When both eyes met
113 the inclusion criteria, the eye to be measured was ran-
114 domly selected. In both sessions, an experienced optom-
115 etrist determined the four variables: high- and low-
116 contrast VA at both distance and near (HCD, LCD,
117 HCN, LCN). For all mesopic VA measurements, the cor-
118 rection used by participants was that obtained in photopic
119 conditions. The subject was allowed at least 10 min to
120 dark-adapt before the tests. The order of the four VA
121 measurements was randomly assigned to balance out var-
122 iables such as fatigue and practice. Each test was
123conducted in exactly the same manner in each subject.
124In session 2, the examiner was masked to the results of
125the first session.
126The ETDRS logMAR chart used has been described in
127detail by Ferris et al. [27]. The chart has five letters per row
128ranging in size from +1.0 to −0.30 logMAR. Each letter read
129correctly on each line was given a score of 0.02 log units.
130Thus, scoring was letter by letter [27]. A loss of 1 line of letters
131corresponds to a logMAR increase of 0.1. LogMAR. Subjects
132were required to identify each letter on the chart until they
133identified a full row of letters incorrectly, at which point the
134test was terminated and acuity calculated. Subjects were en-
135couraged to guess letters if they were unsure.
136For distance VA measurements (HCD, LCD), the room
137light was turned off and the charts (Precision Vision CAT.
138NO. 2110 (HCD 96 %) and CAT. NO. 2153 (LCD 10 %))
139were placed in the original light boxes designed for the
140ETDRS at a distance of 4 m from the patient. The charts
141are front-illuminated by two Phillips 40-watt F40T12
142fluorescent tubes. For the mesopic luminance level re-
143quired (0.75 cd/m2), illumination was reduced by cover-
144ing the fluorescent tubes with an opaque material with
145pinholes [16].
146For near VA measurements (HCN, LCN), the subject
147held the printed test (Precision Vision charts CAT. NO.
1482106 (HCN 96 %) and CAT. NO. 2117 (LCN10%)) at
14940 cm. The room was lit using only a halogen lamp
150connected to a potentiometer, so that the voltage could
151be adjusted to obtain a mesopic luminance level of
1520.75 cd/m2 with the room lighting turned off. This set-
153up provides uniform luminance over the charts. In each
154test, the luminance level was checked using a MAVO-
155SPOT 2 USB luminance meter (Gossen Lighting
156Control).
157Statistical analysis
158Data analysis was performed using Analyse-it for Microsoft
159Excel (Leeds, UK) and SPSS version 19 for Windows (SPSS
160Inc., IBM, Somers, New York).
161The normal distribution of data was confirmed using
162the Shapiro–Wilks test. Repeatability was determined by
163the Bland–Altman method [28], whereby the upper limit
164of expected measured change when a clinically stable
165individual undergoes two visual acuity measurements is
166established. The variables determined were the mean dif-
167ference (MD), the standard deviation of differences (SD),
168the coefficient of repeatability (COR = ±1.96 × SD), and
169the limits of agreement at the 95 % level (MD ± COR).
170The COR is used to identify the change criterion against
171which measured differences are judged. Measured chang-
172es that lie outside this range are considered to reflect true
173clinical changes. The paired t-test was used to identify
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174 any significant systematic bias between measurements,
175 that is, a MD significantly different from zero. The level
176 of significance was set at p<0.05.
177
178 Results
179 The mean VA values obtained for the four tests in the two
180 sessions are provided in Table 1. No evidence (p>0.05) of
181 departure from a normal distribution was detected for any of
182 the VA measurements (HCD, LCD, HCN, LCN).
183 The coefficients of repeatability observed for the different
184 tests are provided in Table 2. Mean differences between the
185 first and second session measurements were always non-sig-
186 nificant, and low in clinical terms (≤1 letter). Repeatability
187 was better for the distance than near tests both at high and low
188 contrast. This was reflected by lower COR recorded for the
189 distance AVs (COR HCD = ±0.11 logMAR, COR LCD = ± 0.11
190 logMAR) than near AVs (COR HCN = ± 0.15, COR LCN = ±
191 0.16 logMAR) and by MDs that were slightly closer to zero
192 for the distance measurements. In contrast, similar COR were
193 observed for HC VAversus LC VA measured both at distance
194 and near.
195 The graphs in Fig. 1 illustrate agreement between the
196 different VA measurements; the narrower the interval, the
197 better repeatability between sessions will be. The distribution
198 of the differences in Fig. 1 shows the points to be symmetri-
199 cally distributed about the MD. This pattern indicates that
200 repeated logMAR VA measures in different sessions show
201 random variability.
202 Discussion
203 To determine how precise a test is and thus to distinguish a
204 true clinical change frommeasurement variability or error, it is
205 essential that the repeatability of its measurements is known.
206 Our study provides estimates of the repeatability of mesopic
207 high-contrast (HC) and low-contrast (LC) visual acuity (VA)
208 ETDRS measurements made at distance and near in healthy
209young individuals. The repeatability coefficient obtained was
210±0.11 logMAR or 1 line for the HCD (96 %) and the LCD
211(10 %) charts, and this value increased to about ±0.16
212logMAR and ±0.15 logMAR for the HCN (96 %) and the
213LCN (10 %) charts respectively. Thus, CORs were lower for
214distance vision measurements (±1 line) than near vision (±1.5
215lines). In other words, in mesopic lighting conditions a pa-
216tient’s logMAR distance visual acuity needs to change by
217more than 1 line or 0.1 logMAR (better or worse) for this
218change to be considered clinically meaningful. In addition,
219HC and LC VA measurements showed similar repeatability
220both at distance and near (Table 2).
221The literature lacks mesopic near ETDRS VA repeat-
222ability data with which to compare our results. In a
223small population sample (N=14), Haegerstrom–Portnoy
224et al. [29] recorded a COR = ±0.94 lines for dark
225Smith–Kettlewell Institute Low Luminance (SKILL)
226chart acuity. This better repeatability is not directly
227comparable to our value for near LC acuity (CORLCN
228= ±1.5 lines) due to the different conditions of SKILL
229dark chart and ETDRS low-contrast chart near AV mea-
230surements. The dark SKILL card used under conditions
231of room lighting, has black letters on a dark gray
232background and was designed to provide low contrast
233(14 %) and simulate reduced luminance (10–15 cd/m2).
234This luminance is, nevertheless, far from the low level
235used in our study (0.75 cd/m2).
236In the only study [30] examining the repeatability of dis-
237tance mesopic VAvalues, a better COR (±0.08 logMAR) than
238observed here was detected for both low- and high-contrast
239measurements. The authors, Pesudovs et al. [30], however,
240used a data set for only three subjects (two women, one man;
241aged 22, 47, and 50 respectively) to calculate repeatability.
242Apart from the small sample size, no details of the time
243interval between repeated measurements are provided. If the
244two measurements were made on the same day, repeatability
245would probably be better because of the learning effect.
246The CORs recorded in our study (±0.11 to ±0.16
247logMAR) are in keeping with previously reported data
248for the use of ETDRS or Bailey–Lovie charts in healthy
249eyes in photopic conditions (±0.07 to ±0.18 logMAR)
t1:1 Table 1 Means ± standard deviations recorded for two repeated
mesopic VA measurements (logMAR)
t1:2 Mesopic VA Session 1 Session 2
t1:3 HCD 0.09±0.10 0.09±0.10
t1:4 LCD 0.44±0.11 0.44±0.12
t1:5 HCN 0.22±0.09 0.19±0.10
t1:6 LCN 0.57±0.11 0.56±0.09
HCD High-contrast distance, LCD Low-contrast distance, HCN High-
contrast near, LCN Low-contrast near
t2:1Table 2 Repeatability of mesopic VA measurements (logMAR)
t2:2Mesopic VA MD P (t-test) COR
t2:3HCD −0.007 0.4 ±0.11
t2:4LCD 0.002 0.8 ±0.11
t2:5HCN −0.020 0.1 ±0.16
t2:6LCN −0.012 0.3 ±0.15
MD Mean difference, COR Coefficient of repeatability, HCD High-
contrast distance, LCD Low-contrast distance, HCN High-contrast near,
LCN Low-contrast near
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250 [24, 31, 25, 32]. Only a few studies have addressed the
251 repeatability of photopic low-contrast VA measurements.
252 In two such studies [33, 34], better test–retest repeatabil-
253 ity was observed at HC than at LC, both at distance and
254 near. Other authors have reported similar repeatability
255 results for photopic HC VA and LC VA at distance [25]
256 (±0.11 and ±0.13 logMAR) and near [31] (±0.12 and
257 ±0.11 logMAR) to those observed for our mesopic mea-
258 surements. These first authors [25] determined distance
259 visual acuities using Bailey–Lovie high (86.8 %) and low
260 (9.4 %) contrast letter charts in 78 healthy subjects (aged
261 21 to 68 years), while the latter, Lam et al. [31], measured
262 near visual acuities in 55 healthy young adults (19 to
263 24 years) using PolyU and Precision Vision near charts
264 in conditions of both high (93 %) and low (16 %)
265 contrast.
266 In our study, mean mesopic VAs obtained at distance
267 were HCD = 0.09±0.10 logMAR and LCD = 0.44±0.11
268logMAR (Table 1). Pesudovs et al. [30] reported mean
269mesopic VAs of HCD = 0.31±0.14 logMAR and LCD =
2700.69±0.12 logMAR at 4 m. Visual acuity was measured
271using standard logMAR high-contrast (96 % Weber) and
272low-contrast (18 % Weber) charts at a mesopic illumina-
273tion level of 0.75 cd/m2. These authors used the same
274testing protocol as for the present study (i.e., a forced-
275choice paradigm and strict end-point criterion of five
276incorrect responses) and the same letter-by-letter
277LogMAR scoring system. Our mean VA values (Table 1)
278were, however, better probably because of the younger
279age and narrower age range of our subjects (mean 22.9,
280range 18–43 years). The subjects in the study by
281Pesudovs et al. [30] were older (mean 50.58 years) and
282the age range (21.6–83.8 years) was much wider. Further
283VA data for different luminance and contrast levels are
284needed to confirm our results and establish normality
285mesopic VA data.
Q1Fig. 1 Bland–Altman plots obtained in the repeatability study of VA measurements (HCD, LCD, HCN, LCN). The central line indicates the mean
difference (MD) between measurements. Dashed lines indicate the upper and lower limits of the 95 % agreement interval (COR)
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286 Our findings indicate that used under mesopic luminance
287 conditions, standard ETDRS charts provide repeatable best-
288 corrected monocular VA measurements. Using this method,
289 the smallest meaningful logMAR VA change detected was 1
290 line at distance and 1.5 lines at near. These criteria are similar
291 to those reported in the literature for photopic VA
292 measurements.
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